AAAAAA
Results:
1-19
|
Results: 19
Authors:
MAZURIER C
RIBBA AS
GAUCHER C
MEYER D
Citation: C. Mazurier et al., MOLECULAR-GENETICS OF VONWILLEBRAND-DISEASE, Annales de genetique, 41(1), 1998, pp. 34-43
Authors:
RIBBA AS
CHEREL G
OBERT B
GIRMA JP
MEYER D
Citation: As. Ribba et al., BOTH LYSINE-643 AND LYSINE-644 IN THE A1 LOOP OF VON-WILLEBRAND-FACTOR ARE NECESSARY FOR THE INTERACTION WITH GLYCOPROTEIN IB, Thrombosis and haemostasis, 1997, pp. 1494-1494
Authors:
VEYRADIER A
OBERT B
HOULLIER A
RIBBA AS
MEYER D
Citation: A. Veyradier et al., A NEW METHOD OF MEASUREMENT OF THE BINDING OF PURIFIED GPIIB-IIIA TO PLASMA AND RECOMBINANT VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 1997, pp. 2578-2578
Authors:
JANEL N
RIBBA AS
CHEREL G
MEYER D
KERBIRIOUNABIAS D
Citation: N. Janel et al., COMPARISON OF THE PRIMARY STRUCTURE OF THE PROPOLYPEPTIDE AND FACTOR-VIII BINDING DOMAIN OF BOVINE AND HUMAN VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 1997, pp. 2614-2614
Authors:
LAVERGNE JM
FRESSINAUD E
GAUCHER C
RIBBA AS
DERLON A
JUHANVAGUE I
GOUDEMAND J
PARQUETGERNEZ A
LELOUCHE F
LEDFORD M
MAZURIER C
MEYER D
Citation: Jm. Lavergne et al., LOCALIZATION IN THE A1 LOOP (AA-509-695) OF VON-WILLEBRAND-FACTOR OF 8 NEW MUTATIONS RESPONSIBLE FOR TYPE 2A OR 2M VON-WILLEBRAND-DISEASE, Thrombosis and haemostasis, 1997, pp. 2669-2669
Authors:
MEYER D
FRESSINAUD E
GAUCHER C
LAVERGNE JM
HILBERT L
RIBBA AS
JORIEUX S
MAZURIER C
Citation: D. Meyer et al., GENE DEFECTS IN 150 UNRELATED FRENCH CASES WITH TYPE-2 VON-WILLEBRAND-DISEASE - FROM THE PATIENT TO THE GENE, Thrombosis and haemostasis, 78(1), 1997, pp. 451-456
Authors:
JANEL N
RIBBA AS
CHEREL G
KERBIRIOUNABIAS D
MEYER D
Citation: N. Janel et al., PRIMARY STRUCTURE OF THE PROPEPTIDE AND FACTOR VIII-BINDING DOMAIN OFBOVINE VON-WILLEBRAND-FACTOR, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1339(1), 1997, pp. 4-8
Authors:
SIGURET V
RIBBA AS
CHRISTOPHE O
CHERET G
OBERT B
ROUAULT C
NISHIKUBO T
MEYER D
GIRMA JP
PIETU G
Citation: V. Siguret et al., CHARACTERIZATION OF RECOMBINANT VON-WILLEBRAND-FACTORS MUTATED ON CYSTEINE-509 OR CYSTEINE-509695, Thrombosis and haemostasis, 76(3), 1996, pp. 453-459
Authors:
GIRMA JP
RIBBA AS
MEYER D
Citation: Jp. Girma et al., STRUCTURE-FUNCTION RELATIONSHIP OF THE A1 DOMAIN OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 74(1), 1995, pp. 156-160
Authors:
RIBBA AS
SIGURET V
CHEREL G
CHRISTOPHE O
OBERT B
NISHIKUBO T
GIRMA JP
PIETU G
MEYER D
Citation: As. Ribba et al., CYSTEINE-509 AND CYSTEINE-695 OF VON-WILLEBRAND-FACTOR PLAY A DISTINCT ROLE IN THE BINDING TO PLATELET GLYCOPROTEIN-IB, Thrombosis and haemostasis, 73(6), 1995, pp. 1159-1159
Authors:
PERRAULT C
LANKHOF H
DENIS C
RIBBA AS
SIXMA JJ
MEYER D
BARUCH D
Citation: C. Perrault et al., ENDOTHELIAL-CELL ADHESION TO VON-WILLEBRAND-FACTOR INVOLVES THE RGD SEQUENCE BUT NO GPLB-BINDING DOMAIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1164-1164
EFFECT OF PLASMID SIZE AN TRANSFORMATION EFFICIENCY BY ELECTROPORATION OF ESCHERICHIA-COLI DH5-ALPHA
Authors:
SIGURET V
RIBBA AS
CHEREL G
MEYER D
PIETU G
Citation: V. Siguret et al., EFFECT OF PLASMID SIZE AN TRANSFORMATION EFFICIENCY BY ELECTROPORATION OF ESCHERICHIA-COLI DH5-ALPHA, BioTechniques, 16(3), 1994, pp. 422
Authors:
SIGURET V
LAVERGNE J
CHEREL G
BOYERNEUMANN C
RIBBA AS
BAHNAK BR
MEYER D
PIETU G
Citation: V. Siguret et al., A NOVEL CASE OF COMPOUND HETEROZYGOSITY WITH NORMANDY TYPE-I VON-WILLEBRAND DISEASE (VWD) - DIRECT DEMONSTRATION OF THE SEGREGATION OF ONE ALLELE WITH A DEFECTIVE EXPRESSION AT THE MESSENGER-RNA LEVEL CAUSING TYPE-I VWD/, Human genetics, 93(2), 1994, pp. 95-102
Authors:
PIETU G
RIBBA AS
CHEREL G
SIGURET V
OBERT B
ROUAULT C
GINSBURG D
MEYER D
Citation: G. Pietu et al., EPITOPE MAPPING OF INHIBITORY MONOCLONAL-ANTIBODIES TO HUMAN VON-WILLEBRAND-FACTOR BY USING RECOMBINANT CDNA LIBRARIES, Thrombosis and haemostasis, 71(6), 1994, pp. 788-792
Authors:
RIBBA AS
CHRISTOPHE O
DERLON A
CHEREL G
SIGURET V
LAVERGNE JM
GIRMA JP
MEYER D
PIETU G
Citation: As. Ribba et al., DISCREPANCY BETWEEN IIA-PHENOTYPE AND IIB-GENOTYPE IN A PATIENT WITH A VARIANT OF VON-WILLEBRAND DISEASE, Blood, 83(3), 1994, pp. 833-841
Authors:
CHRISTOPHE O
RIBBA AS
BARUCH D
OBERT B
ROUAULT C
NIINOMI K
PIETU G
MEYER D
GIRMA JP
Citation: O. Christophe et al., INFLUENCE OF MUTATIONS AND SIZE OF MULTIMERS IN TYPE-II VON-WILLEBRAND DISEASE UPON THE FUNCTION OF VON-WILLEBRAND-FACTOR, Blood, 83(12), 1994, pp. 3553-3561
Authors:
LAVERGNE JM
PIAO Y
RIBBA AS
GIRMA JP
SIGURET V
PIETU G
BOYERNEUMANN C
SCHANDELONG A
BAHNAK BR
MEYER D
Citation: Jm. Lavergne et al., FUNCTIONAL-ANALYSIS OF THE ARG91GLN SUBSTITUTION IN THE FACTOR-VIII BINDING DOMAIN OF VON-WILLEBRAND-FACTOR DEMONSTRATES VARIABLE PHENOTYPIC-EXPRESSION, Thrombosis and haemostasis, 70(4), 1993, pp. 691-696
Authors:
SIGURET V
RIBBA AS
CHRISTOPHE O
GIRMA JP
CHEREL G
MEYER D
PIETU G
Citation: V. Siguret et al., RECOMBINANT VON-WILLEBRAND-FACTOR MUTATED ON CYS-695 DEMONSTRATES THECRUCIAL ROLE OF THE AMINO-ACID IN BINDING TO PLATELET GLYCOPROTEIN-IB, Thrombosis and haemostasis, 69(6), 1993, pp. 980-980
Authors:
CHRISTOPHE O
RIBBA AS
PIETU G
BARUCH D
MEYER D
GIRMA JP
Citation: O. Christophe et al., INFLUENCE OF MUTATIONS AND SIZE OF MULTIMERS IN TYPE-II VON-WILLEBRAND DISEASE UPON THE FUNCTION OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1200-1200
Risultati:
1-19
|